Eli Lilly and Company
5-METHYL-4-FLUORO-THIAZOL-2-YL COMPOUNDS
Last updated:
Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimers disease. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
24 Jul 2019
Issue date:
21 Oct 2021